13F-HR filed by Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-11, with 7 holding rows worth $316,701,000.
- Accession
- 0001104659-22-088716
- Filer
- CIK 1767432
- Filed
- 2022-08-11
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A holdings report, 7 entries on the cover page, a total value of $316,701,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $316,701,000 with VALUE read as thousands by filing date, 13F file number 028-19068. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerAtlas Venture Fund VIII, L.P.028-21502
- included managerAtlas Venture Associates VIII, L.P.028-21501
- included managerAtlas Venture Associates VIII, Inc.028-21503
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INTEGRAL AD SCIENCE HLDNG CO | 45828L108 | COM | 22,722,771 | $225,637,000 | thousands by filing date | |
| DRAFTKINGS INC NEW | 26142V105 | COM CL A | 6,555,608 | $76,504,000 | thousands by filing date | |
| ROKU INC COM CL A | 77543R102 | Stock | 57,707 | $4,740,000 | thousands by filing date | |
| F-STAR THERAPEUTICS INC | 30315R107 | COM | 574,996 | $3,599,000 | thousands by filing date | |
| SNAP INC | 83304A106 | CL A | 245,559 | $3,224,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 209,505 | $2,424,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 292,184 | $573,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-22-088716 | this filing | 2022-08-11 | acceptance time not in the bulk data set |